Hospital
Knoxville Community Hospital INC
Knoxville Community Hospital INC was paid $1.27M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoKNOXVILLE COMMUNITY HOSPITAL INC
KNOXVILLE, IA 50138
KNOXVILLE, IA 50138
33aNPI1922087915assigned 01/10/2006
33bProvider typeCritical Access Hospital
28Total paid$1.27M
24GClaims32,842
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#31 of 79
Median peer was paid$801K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,422 | $142K | |
| 2019 | 4,767 | $205K | |
| 2020 | 3,764 | $147K | |
| 2021 | 5,621 | $224K | |
| 2022 | 7,134 | $249K | |
| 2023 | 5,394 | $192K | |
| 2024incomplete | 2,740 | $116K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 3,034 | 2,852 | $258K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 1,813 | 1,694 | $226K |
| 80053 | Comprehensive metabolic panel | 15% | 3,965 | 3,648 | $189K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9.0% | 2,226 | 2,134 | $115K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.2% | 5,292 | 4,729 | $105K |
| 36415 | Collection of venous blood by venipuncture | 5.6% | 8,186 | 7,036 | $71K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.1% | 376 | 331 | $66K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.3% | 715 | 690 | $42K |
| 86328 | 3.1% | 1,451 | 1,402 | $39K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.0% | 1,742 | 1,019 | $38K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.4% | 530 | 506 | $30K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.4% | 540 | 510 | $30K |
33 more codes
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 751 | $9K |
| 86140 | <1% | 348 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 152 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 196 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 108 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 107 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 60 | $4K |
| 84484 | <1% | 92 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 123 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 206 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 27 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 39 | $2K |
| 86710 | <1% | 40 | $1K | |
| 81001 | <1% | 95 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 27 | $1K |
| 87400 | <1% | 40 | $962.15 | |
| 87430 | <1% | 31 | $888.72 | |
| 36000 | <1% | 108 | $821.87 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 15 | $565.52 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 22 | $543.62 |
| 80061 | Lipid panel | <1% | 12 | $481.67 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 35 | $393.51 |
| 84439 | <1% | 12 | $366.48 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 84 | $330.41 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 84 | $318.53 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15 | $318.09 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 14 | $269.73 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 40 | $214.42 |
| 81025 | <1% | 13 | $165.28 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 25 | $151.38 |
| J7642 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | <1% | 12 | $65.12 |
| 81003 | <1% | 12 | $61.54 | |
| 81015 | <1% | 27 | $37.14 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKINCAID, KEVIN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Knoxville Community Hospital INC | Knoxville, IA | $890K |
| Knoxville Community Hospital INC | Knoxville, IA | $164K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.